This finding was consistent with the work of Wei et al. [16] who demonstrated that in tumor cells, EZH2 can be recruited to the promoter of several negative regulators of mTOR, including Deptor, and regulate their transcription. The gene discussed is DEPTOR; the disease is neoplasm.